8-K//Current report
G1 Therapeutics, Inc. 8-K
Accession 0001628280-24-029426
CIK 0001560241operating
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:35 AM ET
Size
956.4 KB
Accession
0001628280-24-029426
Documents
- 8-Kgthx-20240624.htmPrimary
8-K
- EX-99.1a208finalanalysis_update.htm
EX-99.1
- EX-101.SCHgthx-20240624.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABgthx-20240624_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREgthx-20240624_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICa208finalanalysis_update001.jpg
- GRAPHICa208finalanalysis_update002.jpg
- GRAPHICa208finalanalysis_update003.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001628280-24-029426-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLgthx-20240624_htm.xml
IDEA: XBRL DOCUMENT
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001560241
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:35 AM ET
- Size
- 956.4 KB